1 Azara/Population Health Tool Survey

Azara/Population Health Tool Survey
For the following ques�ons, please respond based on your use of Azara or a third-party popula�on
health tool that you use to look at your Electronic Health Record data.
1. Do healthcare providers in your health center use data from Azara or another popula�on
health tool dashboards to inform clinical decision making for individual pa�ents?
i. Yes, always
ii. Yes, some of the �me
iii. No, never
iv. Not sure
2. Does your health center use data from Azara or another popula�on health tool dashboards
to inform clinical quality improvement efforts related to hypertension control?
i. Yes
ii. No
iii. Not sure
If Yes – How are Azara dashboards used to inform your health center’s clinical quality
improvement efforts related to hypertension control?
•

[Open Ended]

3. Which of the following measures, does your health center use?
Of the following list of hypertension-related measures available in the Azara pla�orm, please
select those your CHC uses for quality improvement, pa�ent tracking, or clinical decision
making?
[select all that apply]
a.
b.
c.
d.
e.
f.
g.

Total _____ Pa�ents 18 to <85 Years of Age with HTN, #
Total _____ Pa�ents in Control (<140/90), #
Total _____ Pa�ents in Control (<130/80), #
Improvement in systolic blood pressure in ______ Pa�ents, %
Average Encounters per Pa�ent (______), #
Confirmatory Repeated Blood Pressure Measurement in _____ Pa�ents, % of visits
Medica�on Intensifica�on in _____ Pa�ents with uncontrolled hypertension, % of
visits
h. Average systolic blood pressure Change A�er Medica�on Intensifica�on in _____
Pa�ents, mm Hg
i. Average Visit Interval in _____ Pa�ents, days
j. High BP and Follow-Up Documented in _____ Pa�ents

k. Repeat visit in 4 weeks a�er uncontrolled HTN in _____ Pa�ents, % of visits
l. Prescrip�on of Fixed Dose Combina�on Product among pa�ents prescribed at least
2 classes of medica�ons in _____ Pa�ents, % of pa�ents
m. Prescrip�on of a CCB or Thiazide or Thiazide-Like Diure�c among Pa�ents Prescribed
At Least One Medica�on, % of pa�ents
n. Encounter percentage in ______ Pa�ents, where the terminal digit in
Systolic/Diastolic BP is zero
o. Uncontrolled HTN on No An�-HTN Medica�ons in _____ Pa�ents, #
p. Uncontrolled HTN on Monotherapy in _____ Pa�ents, #
4. Which of the following measures does your health center find most useful?
Of the following list of hypertension-related measures available in the Azara pla�orm, please
select on a scale of 1 (least useful) to 5 (most useful) how useful the measures are for quality
improvement, pa�ent tracking, or clinical decision making?
[select all that apply]
a.
b.
c.
d.
e.
f.
g.
h.
i.
j.
k.
l.
m.
n.
o.
p.

Total _____ Pa�ents 18 to <85 Years of Age with HTN, #
Total _____ Pa�ents in Control (<140/90), #
Total _____ Pa�ents in Control (<130/80), #
Improvement in systolic blood pressure in ______ Pa�ents, %
Average Encounters per Pa�ent (______), #
Confirmatory Repeated Blood Pressure Measurement in _____ Pa�ents, % of visits
Medica�on Intensifica�on in _____ Pa�ents with uncontrolled hypertension, % of
visits
Average systolic blood pressure Change A�er Medica�on Intensifica�on in _____
Pa�ents, mm Hg
Average Visit Interval in _____ Pa�ents, days
High BP and Follow-Up Documented in _____ Pa�ents
Repeat visit in 4 weeks a�er uncontrolled HTN in _____ Pa�ents, % of visits
Prescrip�on of Fixed Dose Combina�on Product among pa�ents prescribed at least
2 classes of medica�ons in _____ Pa�ents, % of pa�ents
Prescrip�on of a CCB or Thiazide or Thiazide-Like Diure�c among Pa�ents Prescribed
At Least One Medica�on, % of pa�ents
Encounter percentage in ______ Pa�ents, where the terminal digit in
Systolic/Diastolic BP is zero
Uncontrolled HTN on No An�-HTN Medica�ons in _____ Pa�ents, #
Uncontrolled HTN on Monotherapy in _____ Pa�ents, #